Skip to main content

Table 5 Early outcomes

From: Hemostatic efficacy of a flowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial

Variable

GHM N (%), mean (SD), or median [Q1, Q3]

CHM N (%), mean (SD), or median [Q1, Q3]

P value

Mediastinal drains 24 h postoperatively (ml) (mean ± SD)

538.5 ± 229.1

494.7 ± 190.0

0.298

Blood transfusion rates (n, %)

18 (22.5)

14 (17.5)

0.143

Packed RBC (n, %)

5 (6.3)

3 (3.8)

0.067

Packed RBC, ml (mean ± SD)

220 (200, 400)

150 (100, 320)

0.047

FFP (n, %)

20 (25.0)

14 (17.5)

0.034

FFP, unit (mean ± SD)

2.8 ± 2.4

2.1 ± 3.7

0.781

Platelets (n, %)

12 (15.0)

6 (7.5)

0.032

Platelets, unit (mean ± SD)

8.5 ± 5.7

7.8 ± 6.1

0.672

ICU stay, day (mean ± SD)

2.8 ± 1.4

2.3 ± 1.6

0.093

Hospital stay, day (mean ± SD)

8.2 ± 13.8

7.5 ± 10.3

0.520

aMajor complications (n, %)

4 (5.0)

2 (2.5)

0.323

bMinor complications (n, %)

6 (7.5)

14 (17.5)

0.176

In hospital mortality

0

2 (2.5)

0.314

  1. *CHM collagen hemostatic matrix, FFP fresh frozen plasma, GHM gelatin hemostatic matrix, ICU intensive care unit, RBC red blood cell
  2. aMajor postoperative complications: myocardial infarction, sepsis, shock, stroke
  3. bMinor postoperative complications: inotropic support lasting more than 24 h, renal failure, respiratory insufficiency